Information-Derived Mechanistic Hypotheses for Structural Cardiotoxicity.

Area of Science:

• Pharmacology
• Toxicology
• Computational Biology

Background:

• Drug-induced adverse events pose significant safety concerns and economic burdens.
• Understanding the mechanisms of adverse events is crucial for improving drug safety.
• Linking drug adverse events to biological targets can generate new mechanistic hypotheses.

Purpose of the Study:

• To generate mechanistic hypotheses for structural cardiotoxicity by associating adverse events with drug targets.
• To identify potential mechanisms underlying drug-induced heart damage.

Main Methods:

• Utilized data mining and mutual information statistical approaches.
• Integrated data from the FDA Adverse Event Reporting System (FAERS) and ToxCast assay outcomes.
• Focused on associations related to structural cardiotoxicity, including cardiomyocyte damage and viability loss.

Main Results:

• Identified 22 adverse event-assay outcome associations.
• Substantiated 10 implicated targets with existing literature evidence.
• Described detailed mechanisms for two targets, forming putative adverse outcome pathways for cardiotoxicity.
• Highlighted challenges due to limited data availability.

Conclusions:

• The study successfully generated mechanistic hypotheses for drug-induced cardiotoxicity.
• The findings provide a foundation for further investigation into drug safety mechanisms.
• Data limitations present a challenge for deriving robust associations.